Octapharma, a Swiss biopharmaceutical company, has revealed plans for a $1.5 billion investment in Rock Hill, establishing a new U.S. corporate headquarters and a manufacturing facility. The project is set to create more than 1,200 new jobs and relocate an additional 300 executive positions from its Charlotte-based subsidiary, Octapharma Plasma, bringing the total job count to over 1,500. The company’s identity, previously cloaked under a nondisclosure agreement and the codename “Project Palmetto Rock,” was publicly disclosed at a York County Council hearing on June 29, 2026.
This venture represents one of the largest economic development projects in York County’s history. Octapharma, headquartered in Lachen, Switzerland, southeast of Zurich by Lake Zurich, is recognized as the world’s largest privately owned plasma fractionator. The company specializes in developing life-saving medicines and therapies derived from proteins sourced from human plasma and cell lines, addressing critical conditions in haematology (blood disorders), immunotherapy (immune system deficiencies), and critical care (life-threatening situations). With over 11,000 employees globally, Octapharma’s expansion into Rock Hill marks a significant strategic move to bolster its U.S. operations.
The Rock Hill facility will significantly expand Octapharma’s global operational footprint, adding a 3.5 million-liter capacity for plasma processing. This capacity alone will account for approximately one-third of the company’s worldwide plasma fractionation capabilities. Currently, about 88% of Octapharma’s plasma donations originate from company-owned sites across the U.S., with much of it historically being sent to European manufacturing sites for processing. The new Rock Hill plant will enable this U.S.-sourced plasma to be processed domestically, streamlining the supply chain for critical medicines and enhancing efficiency.
The substantial $1.5 billion investment is planned over a 10-year period, demonstrating a long-term commitment to the region. The project includes plans for both a U.S. corporate headquarters campus and an advanced healthcare manufacturing facility. The new jobs are projected to offer competitive salaries, with headquarters positions averaging more than $141,000 annually and manufacturing roles averaging nearly $103,000. These six-figure average salaries are poised to have a significant positive impact on the local workforce and economy, attracting skilled labor and boosting household incomes across York County.
Construction for the new campus is slated to begin late in 2026 at the former Carolina Panthers site, located within the Palmetto Research Park where Palmetto Parkway crosses the interstate. This site holds particular significance for Rock Hill, as it was previously earmarked for a major development that was ultimately cancelled in 2022, representing a notable economic development setback for the city. Octapharma’s commitment now brings a new chapter of investment and job creation to this prominent location.
The public hearing before the York County Council on June 29, 2026, was a crucial step in the project’s progression. During this meeting, the company directly presented its plans, and the community had the opportunity to offer feedback on the proposed tax incentive agreement. The use of a nondisclosure agreement and a codename like “Project Palmetto Rock” is a common practice in large-scale economic development initiatives, designed to protect proprietary information and competitive advantages until formal announcements can be made.
Beyond the direct job creation, the Octapharma project is expected to generate significant indirect economic benefits for Rock Hill and the surrounding areas. This includes increased demand for local support services, construction trades, logistics, and various local businesses. The enhanced tax base for both Rock Hill and York County will provide additional resources for public services and infrastructure improvements. The presence of a global biopharmaceutical leader also elevates the region’s profile, potentially attracting further investment in advanced manufacturing and life sciences sectors.
### Why it matters in Rock Hill
The arrival of Octapharma marks a pivotal moment for Rock Hill’s economic future, bringing a substantial $1.5 billion investment and over 1,500 high-paying jobs. This development is particularly significant for institutions like Winthrop University and York Technical College, which can anticipate increased demand for graduates in science, engineering, and technical fields, fostering a skilled local workforce. The presence of a major biopharmaceutical company also enhances the city’s profile in the healthcare sector, complementing existing employers such as Piedmont Medical Center. Furthermore, the revitalization of the former Carolina Panthers site with a project of this magnitude signals renewed confidence in Rock Hill’s economic resilience and its capacity to attract global industry leaders, contributing to the tax base and overall prosperity of York County.
